Iovance Biotherapeutics Inc. Common Stock vs Sumitomo Mitsui Financial Group Inc Unsponsored American Depositary Shares (Japan) — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.57 (market cap $6.04B), while Sumitomo Mitsui Financial Group Inc Unsponsored American Depositary Shares (Japan) trades at $24.97 (market cap $156.97B). The key difference: Sumitomo Mitsui Financial Group Inc Unsponsored American Depositary Shares (Japan) is far larger — about 26× Iovance Biotherapeutics Inc. Common Stock's market cap, and Sumitomo Mitsui Financial Group Inc Unsponsored American Depositary Shares (Japan) pays a 2.34% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Sumitomo Mitsui Financial Group Inc Unsponsored American Depositary Shares (Japan) for 0 Days on average.
| IOVA | SMFG | |
|---|---|---|
Market Cap | $6.04B | $156.97B |
Volume | 14,805,993 | 1,237,125 |
Sector | Health | Financials |
52-Week High | $14.82 | $27.56 |
52-Week Low | $1.81 | $15.20 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.97B | $12.48T |
Dividend Yield | — | 2.34% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →Sumitomo Mitsui Financial Group is a Japanese financial services company with banking, securities, leasing, and asset management businesses. It serves retail, corporate, and institutional clients.
Read more on SMFG →